New drug duo targets advanced cancers in early trial
Disease control
Ongoing
This study tests whether combining two experimental drugs, BAT8008 and BAT1308, is safe and effective for people with advanced solid tumors that have not responded to standard treatments. About 112 adults will take part, first to find the best dose and then to see how well the dr…
Phase: PHASE1, PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC